Lifespan-Extending Drug Given Late in Life Reverses Age-Related Heart Disease in Mice

Elderly mice suffering from age-related heart disease saw a significant improvement in cardiac function after being treated with the FDA-approved drug rapamycin for just three months. The research, led by a team of scientists at the Buck Institute for Research on Aging, shows how rapamycin impacts mammalian tissues, providing functional insights and possible benefits for […]
Source: Biosingularity - Category: Research Authors: Tags: Biotechnology Source Type: blogs